小儿心脏移植中的当前免疫抑制策略。 - Suppr

Current immunosuppression strategies in pediatric heart transplant.

作者信息

Mylonas Konstantinos S, Soukouli Ioanna, Avgerinos Dimitrios V, Boletis John N

机构信息

Department of Cardiac Surgery, Onassis Cardiac Surgery Center, Athens, Greece.

Department of Nephrology & Renal Transplantation, Laiko General Hospital, National & Kapodistrian University of Athens, Athens, Greece.

出版信息

Immunotherapy. 2022 May 4. doi: 10.2217/imt-2021-0352.

DOI:10.2217/imt-2021-0352

PMID:35510326

Abstract

摘要

相似文献

Current immunosuppression strategies in pediatric heart transplant.

Immunotherapy. 2022 May 4. doi: 10.2217/imt-2021-0352.

Basiliximab as maintenance immunosuppression in heart transplant recipients: A single pediatric center experience.

Pediatr Transplant. 2023 Mar;27(2):e14438. doi: 10.1111/petr.14438. Epub 2022 Nov 17.

Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients.

J Heart Lung Transplant. 2010 May;29(5):517-22. doi: 10.1016/j.healun.2009.11.601. Epub 2010 Jan 12.

Prevention and treatment of severe hemodynamic compromise in pediatric heart transplant patients.

Paediatr Drugs. 2002;4(11):705-15. doi: 10.2165/00128072-200204110-00002.

Clinical approach to acute cellular rejection from the pediatric heart transplant society.

Pediatr Transplant. 2022 Dec;26(8):e14393. doi: 10.1111/petr.14393.

Immunosuppressive T-cell antibody induction for heart transplant recipients.

Cochrane Database Syst Rev. 2013 Dec 2;2013(12):CD008842. doi: 10.1002/14651858.CD008842.pub2.

Strategies to prevent cellular rejection in pediatric heart transplant recipients.

Paediatr Drugs. 2010 Dec 1;12(6):391-403. doi: 10.2165/11535990-000000000-00000.

Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?

Paediatr Drugs. 2011 Feb 1;13(1):49-69. doi: 10.2165/11538530-000000000-00000.

Maintenance steroid use at 30 days post-transplant and outcomes of pediatric heart transplantation: A propensity matched analysis of the Pediatric Heart Transplant Study database.

J Heart Lung Transplant. 2015 Aug;34(8):1066-72. doi: 10.1016/j.healun.2015.03.003. Epub 2015 Mar 20.

Risk stratification to determine the impact of induction therapy on survival, rejection and adverse events after pediatric heart transplant: A multi-institutional study.

J Heart Lung Transplant. 2018 Apr;37(4):458-466. doi: 10.1016/j.healun.2017.05.010. Epub 2017 May 11.

引用本文的文献

Recent advances in biological pumps as a building block for bioartificial hearts.

Front Bioeng Biotechnol. 2023 Jan 20;11:1061622. doi: 10.3389/fbioe.2023.1061622. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Current immunosuppression strategies in pediatric heart transplant.

作者信息

Mylonas Konstantinos S, Soukouli Ioanna, Avgerinos Dimitrios V, Boletis John N

机构信息

Department of Cardiac Surgery, Onassis Cardiac Surgery Center, Athens, Greece.

Department of Nephrology & Renal Transplantation, Laiko General Hospital, National & Kapodistrian University of Athens, Athens, Greece.

出版信息

Immunotherapy. 2022 May 4. doi: 10.2217/imt-2021-0352.

DOI:10.2217/imt-2021-0352

PMID:35510326

Abstract

摘要

相似文献

Current immunosuppression strategies in pediatric heart transplant.

Immunotherapy. 2022 May 4. doi: 10.2217/imt-2021-0352.

Basiliximab as maintenance immunosuppression in heart transplant recipients: A single pediatric center experience.

Pediatr Transplant. 2023 Mar;27(2):e14438. doi: 10.1111/petr.14438. Epub 2022 Nov 17.

Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients.

J Heart Lung Transplant. 2010 May;29(5):517-22. doi: 10.1016/j.healun.2009.11.601. Epub 2010 Jan 12.

Prevention and treatment of severe hemodynamic compromise in pediatric heart transplant patients.

Paediatr Drugs. 2002;4(11):705-15. doi: 10.2165/00128072-200204110-00002.

Clinical approach to acute cellular rejection from the pediatric heart transplant society.

Pediatr Transplant. 2022 Dec;26(8):e14393. doi: 10.1111/petr.14393.

Immunosuppressive T-cell antibody induction for heart transplant recipients.

Cochrane Database Syst Rev. 2013 Dec 2;2013(12):CD008842. doi: 10.1002/14651858.CD008842.pub2.

Strategies to prevent cellular rejection in pediatric heart transplant recipients.

Paediatr Drugs. 2010 Dec 1;12(6):391-403. doi: 10.2165/11535990-000000000-00000.

Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?

Paediatr Drugs. 2011 Feb 1;13(1):49-69. doi: 10.2165/11538530-000000000-00000.

Maintenance steroid use at 30 days post-transplant and outcomes of pediatric heart transplantation: A propensity matched analysis of the Pediatric Heart Transplant Study database.

J Heart Lung Transplant. 2015 Aug;34(8):1066-72. doi: 10.1016/j.healun.2015.03.003. Epub 2015 Mar 20.

Risk stratification to determine the impact of induction therapy on survival, rejection and adverse events after pediatric heart transplant: A multi-institutional study.

J Heart Lung Transplant. 2018 Apr;37(4):458-466. doi: 10.1016/j.healun.2017.05.010. Epub 2017 May 11.

引用本文的文献

Recent advances in biological pumps as a building block for bioartificial hearts.

Front Bioeng Biotechnol. 2023 Jan 20;11:1061622. doi: 10.3389/fbioe.2023.1061622. eCollection 2023.

Current immunosuppression strategies in pediatric heart transplant.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Current immunosuppression strategies in pediatric heart transplant.

作者信息

机构信息

出版信息

相似文献

引用本文的文献